Laboratory evaluation of hypercoagulability with venous or arterial thrombosis - Venous thromboembolism, myocardial infarction, stroke, and other conditions

被引:0
作者
Van Cott, EM
Laposata, M
Prins, MH
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[2] Univ Maasticht, Dept Clin Epidemiol, Maastricht, Netherlands
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective.-To provide recommendations for hypercoagulation testing for patients with venous, arterial, or neurovascular thrombosis, as reflected in the medical literature and the consensus opinion of recognized experts in the field. Data Sources, Extraction, and Synthesis.-The authors extensively examined the literature and current practices, and prepared a draft manuscript with preliminary recommendations. The draft manuscript was circulated to each of the expert participants (n = 30) in the consensus conference prior to the convening of the conference. The manuscript and recommendations were then presented at the conference for discussion. Recommendations were accepted if a consensus of the 28 experts attending the conference was reached. The discussions were also used to revise the manuscript into its final form. Conclusions.-The resulting article provides 17 recommendations for hypercoagulation testing in the setting of venous, arterial, or neurovascular thrombosis. The supporting evidence for test selection is analyzed and cited, and consensus recommendations for test selection are presented. Issues for which a consensus was not reached at the conference are also discussed.
引用
收藏
页码:1281 / 1295
页数:15
相关论文
共 229 条
[51]  
Diehm C, 2001, NEW ENGL J MED, V344, P230
[52]   Interaction of coagulation defects and cardiovascular risk factors - Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A [J].
Doggen, CJM ;
Cats, VM ;
Bertina, RM ;
Rosendaal, FR .
CIRCULATION, 1998, 97 (11) :1037-1041
[53]  
Douay X, 1998, ACTA NEUROL SCAND, V98, P124
[54]   Role of factor V Leiden mutation in patients with angiographically demonstrated coronary artery disease [J].
Dunn, ST ;
Roberts, CR ;
Schechter, E ;
Moore, WE ;
Lee, ET ;
Eichner, JE .
THROMBOSIS RESEARCH, 1998, 91 (02) :91-99
[55]   Serial measures of plasma homocyst(e)ine after acute myocardial infarction [J].
Egerton, W ;
Silberberg, J ;
Crooks, R ;
Ray, C ;
Xie, LJ ;
Dudman, N .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (09) :759-&
[56]  
Eichinger S, 1997, THROMB HAEMOSTASIS, V77, P624
[57]  
Eichinger S, 1999, THROMB HAEMOSTASIS, V81, P14
[58]  
Eichinger S, 1998, THROMB HAEMOSTASIS, V80, P566
[59]   No association between the 20210 G/A prothrombin gene mutation and premature coronary artery disease [J].
Eikelboom, JW ;
Baker, RI ;
Parsons, R ;
Taylor, RR ;
van Bockxmeer, FM .
THROMBOSIS AND HAEMOSTASIS, 1998, 80 (06) :878-880
[60]   Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial [J].
Evans, RW ;
Shaten, BJ ;
Hempel, JD ;
Cutler, JA ;
Kuller, LH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) :1947-1953